Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: Gene expression analysis of intestinal IL-8, IL-17 A and IL-10 in patients with celiac and inflammatory bowel diseases.
Aghamohamad E, Asri N, Odak A, Rostami-Nejad M, Chaleshi V, Hajinabi Y, Eslami M, Haftcheshmeh SM, Gholam-Mostafaei FS, Asadzadeh-Aghdaei H, Masotti A, Zali MR. Aghamohamad E, et al. Among authors: odak a. Mol Biol Rep. 2024 Apr 24;51(1):569. doi: 10.1007/s11033-024-09440-6. Mol Biol Rep. 2024. PMID: 38658466 No abstract available.
Gene expression analysis of intestinal IL-8, IL-17 A and IL-10 in patients with celiac and inflammatory bowel diseases.
Aghamohamadi E, Asri N, Odak A, Rostami-Nejad M, Chaleshi V, Hajinabi Y, Eslami M, Mohammadian Haftcheshmeh S, Gholam-Mostafaei FS, Asadzadeh-Aghdaei H, Masotti A, Zali MR. Aghamohamadi E, et al. Among authors: odak a. Mol Biol Rep. 2022 Jul;49(7):6085-6091. doi: 10.1007/s11033-022-07397-y. Epub 2022 May 8. Mol Biol Rep. 2022. PMID: 35526253
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial.
Boulad F, Maggio A, Wang X, Moi P, Acuto S, Kogel F, Takpradit C, Prockop S, Mansilla-Soto J, Cabriolu A, Odak A, Qu J, Thummar K, Du F, Shen L, Raso S, Barone R, Di Maggio R, Pitrolo L, Giambona A, Mingoia M, Everett JK, Hokama P, Roche AM, Cantu VA, Adhikari H, Reddy S, Bouhassira E, Mohandas N, Bushman FD, Rivière I, Sadelain M. Boulad F, et al. Among authors: odak a. Nat Med. 2022 Jan;28(1):63-70. doi: 10.1038/s41591-021-01554-9. Epub 2022 Jan 3. Nat Med. 2022. PMID: 34980909 Free PMC article. Clinical Trial.
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection.
Eyquem J, Mansilla-Soto J, Giavridis T, van der Stegen SJ, Hamieh M, Cunanan KM, Odak A, Gönen M, Sadelain M. Eyquem J, et al. Among authors: odak a. Nature. 2017 Mar 2;543(7643):113-117. doi: 10.1038/nature21405. Epub 2017 Feb 22. Nature. 2017. PMID: 28225754 Free PMC article.